Nerve Regeneration Market Growth Register a CAGR of 11.3% to 2023 Spurred by Rising Incidences of Neurological Disorders | Latest MRFR Brief 2019

Nerve Regeneration Market Development and Growth Insights 2019 By Product (Biomaterials, Nerve Conduits, Nerve Protectors, others), By Application (Surgery, Prognosis, Autologous Nerve Grafting, others) By Methods (Stem Cell Therapy, Direct Nerve Repair, Nerve Grafting, others) - Global Forecast till 2023

Pune, India - July 8, 2019 /MarketersMedia/ —

Nerve Regeneration Market Scope

Market Research Future (MRFR) forecasts that the global nerve regeneration market is expected to garner 11.3% CAGR during the forecast period of 2017-2023.

The increase in prevalence of neurological disorders due to the rise in number of people afflicted with genetic disorders is observed as a strong factor that is likely to amplify the nerve regeneration market. The increase in geriatric population, which is prone to neurodegenerative disorders like Alzheimer and Parkinson disorder is also expected to escalate the nerve regeneration market growth. Traumatic injuries can severely damage nerve functions and hence, demand for effective neurological treatments. The effectiveness of nerve regeneration treatments to cater medical attention to the rising number of patients suffering from nerve injuries is likely to cast a positive impact on the market growth.

Avail Free Sample @ https://www.marketresearchfuture.com/sample_request/1202

Nerve regeneration treatment includes several surgeries that can be performed easily. The growing popularity of nerve regeneration treatment among people due to its flexibility is another factor that is expected to impel the nerve regeneration market growth. However, despite such robust market drivers, the high cost and unawareness about nerve regeneration procedures can hinder the market expansion.

Market Top Key Players

Stryker Corporation (U.S.).St. Jude Medical (U.S.)

Integra Life Sciences Corporation (U.S.)

AxoGen Inc. (U.S.)

Xcelthera INC. (U.S)

Cyberonics Inc. (U.S.)

Medtronic (U.S.)

Polyganics (the Netherlands)

Boston Scientific Corporation (U.S.)

Neurotex Limited (U.K)

Orthomed S.A.S. (France)

and Baxter International Inc (U.S.).

Segmental Overview

The nerve regeneration market has been segmented on the basis of application, product, and method.

Based on the application, the nerve regeneration market has been segmented into nerve grafting, autologous surgery, prognosis, and others. The application segment of the market is likely to garner a considerable CAGR during the forecast period.

Based on the product, the nerve regeneration market has been segmented into biomaterials, nerve protectors, nerve conduit, and others.

Based on the method, the nerve regeneration market has been segmented into nerve grafting, stem cell therapy, direct nerve repair, and others.

Access Premium Research Page along with Detailed Table of Content at https://www.marketresearchfuture.com/reports/nerve-regeneration-market-1202

Regional Outlook

Based on region, the nerve regeneration market has been segmented into Americas, Asia Pacific, Europe, and the Middle East & Africa.

The Americas is expected to lead the global nerve regeneration market due to its largest patient pool. The well-structured medical base and hike in the healthcare expenditure are factors that are likely to bolster the regional market. Moreover, robust research and developmental activities concerning nerve regeneration are also expected to fuel its market growth.

The regional insights suggest that Europe holds the second position in the global acquired nerve regeneration market owing to the government support for research & development and availability of funds for research.

Europe, followed by lead, is likely to stand second in the global nerve regeneration market. The increase in funding for research and developmental activities is identified as a reason that is anticipated to fuel the market growth.

The growing nerve regeneration market in Asia Pacific is likely to demonstrate a substantial growth over the assessment period. The continuous upgradations in technology, backing the existence of secure medical infrastructure in the region is expected to shoot up the market growth. Other factors like huge patient pool, increase in incidences of nerve injuries, and surge in medical expenditure in countries like India and China is also observed to boost the regional nerve regeneration market.

Due to the lack of technical support and unorganized medical infrastructure in the Middle East Asia and Africa the nerve regeneration market is expected to hold the least market share.

LIST OF TABLES

Table 1 Nerve Regeneration Industry Synopsis, 2017-2023

Table 2 Global Nerve Regeneration Market Estimates And Forecast, 2017-2023, (USD Million)

Table 3 Global Nerve Regeneration Market By Region, 2017-2023, (USD Million)

Table 4 Global Nerve Regeneration Market By Product, 2017-2023, (USD Million)

Table 5 Global Nerve Regeneration Market By Application, 2017-2023, (USD Million)

Table 6 Global Nerve Regeneration Market By Method, 2017-2023, (USD Million)

Table 7 North America Nerve Regeneration Market By Product, 2017-2023, (USD Million)

Table 8 North America Nerve Regeneration Market By Application, 2017-2023, (USD Million)

Table 9 North America Nerve Regeneration Market By Method, 2017-2023, (USD Million)

…To be Continued.

Ask for an Amazing Discount at https://www.marketresearchfuture.com/check-discount/1202

Industry News

May 2019: Orthocell, a regenerative medicine company, has raised $10.6 million by placing shares at 40¢ each with sophisticated and professional and investors that include existing shareholders.

Contact Info:
Name: Mr. Akash Anad.
Email: Send Email
Organization: Market Research Future
Address: Magarpatta Road, Hadapsar, Pune
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/nerve-regeneration-market-1202%20

Source URL: https://marketersmedia.com/nerve-regeneration-market-growth-register-a-cagr-of-113-to-2023-spurred-by-rising-incidences-of-neurological-disorders-latest-mrfr-brief-2019/88893645

Source: MarketersMedia

Release ID: 88893645